| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/17/2008 | CN101264317A Preparation of orally-administered protolysate |
| 09/17/2008 | CN101264316A Preparation of medicinal protolysate |
| 09/17/2008 | CN101264255A Chinese medicinal composition for treating diabetes and preparation thereof |
| 09/17/2008 | CN101264226A Quality detecting method of diabetes treating medicine |
| 09/17/2008 | CN101264203A Chinese and western medicine composition for treating diabetes |
| 09/17/2008 | CN101264169A Qingchun jiangan capsule and manufacturing technique |
| 09/17/2008 | CN101264158A Application of Chinese medicine composing prescription in preparing medicaments for treating metabolic syndrome |
| 09/17/2008 | CN101264147A Content detecting method for shazhajing hypolipemic capsule |
| 09/17/2008 | CN101264140A Medicinal composition for preventing birth defect and improving memory and intelligence |
| 09/17/2008 | CN101264129A Sugar-free heart-supplementing dracocephali moldavica granula |
| 09/17/2008 | CN101264122A Hypericum extract, its making method and medicinal composition and use for treating diabetes |
| 09/17/2008 | CN101264121A Blood fat reducing health products and preparation |
| 09/17/2008 | CN101264101A Medicinal composition for preventing birth defect and improving memory in prepotency |
| 09/17/2008 | CN101264095A Application of polydatin in preventing and controlling obesity and relieving insulin resistance |
| 09/17/2008 | CN101264093A Compositions for increasing energy in vivo |
| 09/17/2008 | CN101264091A Blood-fat reducing composition and uses thereof |
| 09/17/2008 | CN101264073A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 09/17/2008 | CN101264072A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 09/17/2008 | CN101264066A Rutin osmotic pump preparations and preparation thereof |
| 09/17/2008 | CN101263910A Fat-reducing science and technology cooking |
| 09/17/2008 | CN101263908A Blood fat reducing soft capsule health care food and its preparation |
| 09/17/2008 | CN101263895A Blood sugar reducing science and technology cooking |
| 09/17/2008 | CN101263892A Medlar dietary cure health preserving noodle |
| 09/17/2008 | CN101263857A Blood sugar reducing tea and making method thereof |
| 09/17/2008 | CN101263855A Honey rose beverage |
| 09/17/2008 | CN101263854A Honey glossy ganoderma tea |
| 09/17/2008 | CN100418977C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 09/17/2008 | CN100418968C Pirazino(aza)indole derivatives |
| 09/17/2008 | CN100418967C Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 09/17/2008 | CN100418965C Imidazopyridine derivatives |
| 09/17/2008 | CN100418944C Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 09/17/2008 | CN100418575C Compound calcium preparation for astronaut |
| 09/17/2008 | CN100418566C Health-caring essence and preparation method thereof |
| 09/17/2008 | CN100418544C Anti-glycuresis preparation obtained from plant Humboldtia decurrens and preparation method thereof |
| 09/17/2008 | CN100418535C Aescin medicine composition and its prepn process and use |
| 09/17/2008 | CN100418430C Biological health tea |
| 09/16/2008 | US7425642 Anti-diabetic activity, improves insulin resistance and control the blood glucose level more safely, simulates activity of peroxisome proliferator-activated receptor; (1-{(2E)-3-[3-(Bromomethyl)phenyl]prop-2-en-1-yl}-1H-pyrrol-2-yl)(4-methyl-phenyl)methanone |
| 09/16/2008 | US7425639 Process |
| 09/16/2008 | US7425637 mitogen-activated protein/extracellular signal-regulated (MAP/ERK)Kinase pathways; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide; hyperproliferative diseases; anticarcinogenic and antiinflammatory agent |
| 09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
| 09/16/2008 | US7425577 Lipase-colipase inhibitor |
| 09/16/2008 | US7425571 synergistic admnistration of a weight-loss promoting anticonvulsant and a norepinephrine or dopamine agonist; hypotensive, antidiabetic, anticholesterol agents |
| 09/16/2008 | US7425567 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 09/16/2008 | US7425566 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 09/16/2008 | US7425563 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 09/16/2008 | US7425331 Protein A methods of use |
| 09/16/2008 | CA2480429C Novel therapeutical use of agonist ligands specific to g2a receptor |
| 09/16/2008 | CA2356422C Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications |
| 09/12/2008 | WO2008109742A1 Modulation of complement system activation for treatment of bleeding-related inflammation |
| 09/12/2008 | WO2008109727A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
| 09/12/2008 | WO2008109702A1 Compounds and compositions as modulators of gpr119 activity |
| 09/12/2008 | WO2008109700A1 Ppar active compounds |
| 09/12/2008 | WO2008109697A2 Ppar active compounds |
| 09/12/2008 | WO2008109591A1 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| 09/12/2008 | WO2008108958A2 Benzimidazole derivatives and methods of use thereof |
| 09/12/2008 | WO2008108957A2 Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain |
| 09/12/2008 | WO2008108572A1 Novel crystal forms of pyrrolylheptanoic acid derivatives |
| 09/12/2008 | WO2008108486A1 1-biarylazetidinone derivatives |
| 09/12/2008 | WO2008108445A1 Benzoxazepine derivatives and use thereof |
| 09/12/2008 | WO2008108298A1 Agent for reducing visceral fat |
| 09/12/2008 | WO2008107910A2 Use of caralluma extracts in the inhibition of adipogenesis and a method of inhibition for the same |
| 09/12/2008 | WO2008107455A1 Indazoles used to treat estrogen receptor beta mediated disorders |
| 09/12/2008 | WO2008107399A1 Substituted oxindole compounds |
| 09/12/2008 | WO2008107184A1 Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity |
| 09/12/2008 | WO2008107183A1 Cynara scolymus extracts and compositions containing them |
| 09/12/2008 | WO2008107182A2 Formulations of al pha-amylas e inhibitors of p. vulgaris with alpha-glucos idade inhibitores of s. oblonga or s. reticulata useful in the treatment of diabetes and obesity |
| 09/12/2008 | WO2008106860A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof |
| 09/12/2008 | WO2008106779A1 Gastrin compound for diabetes treatment |
| 09/12/2008 | WO2008106775A1 Combination treatment for diabetes using an egf receptor ligand and a gastrin compound |
| 09/12/2008 | WO2008106772A1 Phospholipid compositions with improved bioavailability and methods for their use |
| 09/12/2008 | WO2008106763A1 Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections |
| 09/12/2008 | WO2008087560A3 Thiazolidine derivatives and methods for the preparation thereof |
| 09/12/2008 | WO2008074935A3 Biologically active compositions, methods for producing the same and biological applications |
| 09/12/2008 | WO2008074824A3 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd) |
| 09/12/2008 | WO2008015699A3 A process for manufacturing an herbal composition for curing diabetes and herbal composition made thereof |
| 09/12/2008 | WO2007073176A3 Composition comprising a polyunsaturated fatty acid for improving membrane composition |
| 09/12/2008 | CA2696232A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof |
| 09/12/2008 | CA2680109A1 Indazoles used to treat estrogen receptor beta mediated disorders |
| 09/12/2008 | CA2680078A1 Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity |
| 09/12/2008 | CA2680076A1 Cynara scolymus extracts and compositions containing them |
| 09/12/2008 | CA2680038A1 Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections |
| 09/12/2008 | CA2679944A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
| 09/12/2008 | CA2679844A1 Ppar active compounds |
| 09/12/2008 | CA2679809A1 Benzimidazole derivatives and methods of use thereof |
| 09/12/2008 | CA2679807A1 Piperidine derivatives and methods of use thereof |
| 09/12/2008 | CA2679411A1 Ppar active compounds |
| 09/12/2008 | CA2679317A1 Novel crystal forms of pyrrolylheptanoic acid derivatives |
| 09/12/2008 | CA2679249A1 Compounds and compositions as modulators of gpr119 activity |
| 09/12/2008 | CA2677030A1 Agent for reducing visceral fat |
| 09/12/2008 | CA2675312A1 1-biarylazetidinone derivative |
| 09/11/2008 | US20080221219 Oleamide-containing composition for animal consumption |
| 09/11/2008 | US20080221217 Phenyl Compounds and Their Use in the Treatment of Type II Diabetes |
| 09/11/2008 | US20080221202 treatment of disorders and conditions modulated by at least one progesterone or glucocorticoid receptor; 11-(4-Dimethylamino-phenyl)-1-hydroxy-12a-methyl-1-prop-1-ynyl-1,3,4,4a,4b,5,6,9,10,11,12,12a-dodecahydro-2-oxa-chrysen-8-one |
| 09/11/2008 | US20080221200 Dipeptidyl-peptidase (DPP) IV inhibitor N-peptidyl-O-aroyl hydroxylamine and immunosuppressor or immunomodulator; autoimmune diseases, graft rejection; antidiabetic agents; Alzheimer's, Parkinson's disease; obesity, retinopathy, nephropathy, neuropathy, schizophrenia; cognition activators |
| 09/11/2008 | US20080221198 Novel Crystalline Forms of Antidiabetic Compounds |
| 09/11/2008 | US20080221179 SUBSTITUTED PHENOXY AMINOTHIAZOLONES as estrogen related receptor-alpha modulators |
| 09/11/2008 | US20080221176 treatment of diabetes mellitus, cardiovascular disease, dyslipidemia, artherosclerosis, peripheral vascular disease, inflammation, cancer, and diseases of the central nervous system; 1,1,1,3,3,3-hexafluoro-2-{4-[methyl(phenylmethyl)amino]phenyl}-2-propanol |
| 09/11/2008 | US20080221172 Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection |
| 09/11/2008 | US20080221164 Inhibitors of Sodium Glucose Co-Transporter 2 and Methods of Their Use |